Results 141 to 150 of about 37,867 (253)

Pigment visibility on rectal swabs used to detect enteropathogens: A prospective cohort study [PDF]

open access: yes, 2019
Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE) AND Pediatric Emergency Research Canada (PERC),   +13 more
core   +2 more sources

Impact of CodY protein on metabolism, sporulation and virulence in Clostridioides difficile ribotype 027

open access: gold, 2019
Nadine Daou   +12 more
openalex   +2 more sources

An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily [PDF]

open access: hybrid, 2021
Alice Annalisa Medaglia   +7 more
openalex   +1 more source

Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort

open access: yesBMC Infectious Diseases
Background Recurrent Clostridioides difficile infection is most effectively treated with faecal microbiota transplantation. Swedish and European guidelines suggest faecal microbiota transplantation after a first or second recurrence, respectively.
Måns Stefansson   +5 more
doaj   +1 more source

Clostridioides difficile: Treating Sustained Antibiotic Responders With Fecal Microbiota Transplantation Does Not Improve Efficacy [PDF]

open access: hybrid
Sara Ellegaard Paaske   +10 more
openalex   +1 more source

Additional file 3 of Gut metabolites predict Clostridioides difficile recurrence

open access: gold, 2022
Jennifer J. Dawkins   +6 more
openalex   +1 more source

In silico interaction of catalytic domain of Clostridioides difficile toxins TcdA and TcdB with some selected compounds from the SuperNatural 3.0 database

open access: yesKuwait Journal of Science
Clostridioides difficile is a pathogenic bacterium responsible for antibiotic-associated diarrhea globally. The pathogenesis of this bacterium is due to its virulence toxins, which inactivate the small GTPases from the Rho and Ras families in host cells,
doaj   +1 more source

Microbiota Restoration Therapies for Recurrent Clostridioides difficile Infection Reach an Important New Milestone [PDF]

open access: yes
Microbiota restoration therapy has become a standard treatment for recurrent Clostridioides difficile infection (rCDI). In this article, we review the studies supporting the licensure of two live biotherapeutic products (LBPs) designed to prevent rCDI ...
DuPont, Andrew W   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy